Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.34), in-line with the analyst estimate of ($0.34).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.